Iradimed (IRMD) Return on Capital Employed (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Iradimed | 1.17 Bn | 1.11 Bn | 16.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 194.00 |
| Dec 31, 2025 | -1,955.00 |
| Sep 30, 2025 | 43.00 |
| Jun 30, 2025 | 25.00 |
| Mar 31, 2025 | -29.00 |
| Dec 31, 2024 | -35.00 |
| Sep 30, 2024 | -92.00 |
| Jun 30, 2024 | 111.00 |
| Mar 31, 2024 | -208.00 |
| Dec 31, 2023 | 228.00 |
| Sep 30, 2023 | 53.00 |
| Jun 30, 2023 | 203.00 |
| Mar 31, 2023 | 131.00 |
| Dec 31, 2022 | 102.00 |
| Sep 30, 2022 | 32.00 |
| Jun 30, 2022 | 421.00 |
| Mar 31, 2022 | 227.00 |
| Dec 31, 2021 | 289.00 |
| Sep 30, 2021 | 293.00 |
| Jun 30, 2021 | 706.00 |
| Mar 31, 2021 | 157.00 |
| Dec 31, 2020 | -243.00 |
| Sep 30, 2020 | -277.00 |
| Jun 30, 2020 | -851.00 |
| Mar 31, 2020 | -215.00 |
| Dec 31, 2019 | -46.00 |
| Sep 30, 2019 | 113.00 |
| Jun 30, 2019 | 19.00 |
| Mar 31, 2019 | -13.00 |
| Dec 31, 2018 | 97.00 |
| Sep 30, 2018 | 229.00 |
| Jun 30, 2018 | 341.00 |
| Mar 31, 2018 | 358.00 |
| Dec 31, 2017 | -160.00 |
| Sep 30, 2017 | -716.00 |
| Jun 30, 2017 | -887.00 |
| Mar 31, 2017 | -1,204.00 |
| Dec 31, 2016 | -840.00 |
| Sep 30, 2016 | -278.00 |
| Jun 30, 2016 | 318.00 |
| Mar 31, 2016 | 336.00 |
| Dec 31, 2015 | 726.00 |
| Sep 30, 2015 | 736.00 |
| Jun 30, 2015 | 274.00 |
| Mar 31, 2015 | 579.00 |
| Dec 31, 2014 | -1,042.00 |